LOS ANGELES–(BUSINESS WIRE)–#childrenshealth–Third paragraph, first sentence of release dated March 28, 2023 has been removed and the paragraph should now begin: “Khouri most recently served as Executive Vice President and Chief Strategy and Transformation Officer since December 2020, and has held several other leadership roles during her CHLA tenure.” The updated release reads: CHILDREN’S HOSPITAL … [Read more…]

CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2023 on Tuesday, May 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on … [Read more…]

ST. PAUL, Minn.–(BUSINESS WIRE)–Ecolab will host a live webcast of its first quarter earnings conference call to discuss 2023 first quarter results. A news release containing first quarter results is expected to be issued before market open on May 2, 2023. Details for the public webcast are as follows: TIME: 1:00 p.m. Eastern Time DATE: … [Read more…]

LOUISVILLE, Ky.–(BUSINESS WIRE)–Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2023 (1Q23) on Wednesday, April 26, 2023, at 6:30 a.m. Eastern time. The company will host a conference call at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2023. To … [Read more…]

KEYTRUDA is approved for the treatment of adult and pediatric patients with unresectable or metastatic MSI-H or dMMR solid tumors, as determined by an FDA-approved test, that have progressed following prior treatment and who have no satisfactory alternative treatment options RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside of the United States and … [Read more…]

Company grows agency services revenue and wins three industry awards CAMPBELL, Calif. & NEW YORK–(BUSINESS WIRE)–$LVWD #earnings–LiveWorld, Inc. (OTC Markets: LVWD), a full-service digital agency with deep expertise in social, creative, and compliance for pharma, healthcare, and other industries today announced that its agency services revenues have more than doubled over the last two years … [Read more…]

Approaching 60 clinical sites participating in pivotal Phase 2/3 trial of epetraborole in treatment-refractory Mycobacterium avium complex (MAC) lung disease to date Opened up sites in three additional countries — Japan, South Korea, and Australia in addition to the U.S.; Japan has some of the highest rates of MAC lung disease in the world Activities … [Read more…]

54% Increase in Revenue in the Fourth Quarter 2022 Versus Third Quarter 2022 NEW YORK–(BUSINESS WIRE)–Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), a technology company transforming the company health plan for employers that self-fund their healthcare, today reported financial results for the fourth quarter and year ended December 31, 2022. The Company’s consolidated results … [Read more…]

HOUSTON–(BUSINESS WIRE)–Coya Therapeutics, Inc. (Nasdaq: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics and cell therapies intended to enhance function of Regulatory T Cells (Tregs) function, today announced its financial results for fiscal year ended December 31, 2022, and provided a clinical and business update. FY 2022 and Early 2023 Highlights In … [Read more…]

Basketball officiating program to provide economic stability and critical job training skills for underserved communities, including youth transitioning out of foster care. ATLANTA–(BUSINESS WIRE)–Amerigroup Georgia and the International Association of Approved Basketball Officials, Inc. (IAABO) today announced a partnership to train individuals from underserved communities across Atlanta, including youth transitioning out of foster care, to … [Read more…]